Simcha Samuel

4.5k total citations · 2 hit papers
27 papers, 3.7k citations indexed

About

Simcha Samuel is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Simcha Samuel has authored 27 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Simcha Samuel's work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (8 papers) and Immune Cell Function and Interaction (7 papers). Simcha Samuel is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (8 papers) and Immune Cell Function and Interaction (7 papers). Simcha Samuel collaborates with scholars based in Israel, United States and Germany. Simcha Samuel's co-authors include Reuven Or, Shimon Slavin, Arnon Nagler, Aliza Ackerstein, Memet Aker, Avraham Amar, Gàbor Varadi, Mark Kirschbaum, E Naparstek and Chaim Brautbar and has published in prestigious journals such as Blood, Clinical Infectious Diseases and American Heart Journal.

In The Last Decade

Simcha Samuel

27 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

1998 1.6k citations Shimon Slavin, Arnon Nagler et al. Blood profile →
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

1998 1.5k citations Shimon Slavin, Arnon Nagler et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simcha Samuel Israel	15	3.2k	1.3k	987	662	623	27	3.7k
Gàbor Varadi United States	16	3.2k 1.0×	1.3k 1.0×	1.1k 1.1×	625 0.9×	638 1.0×	45	3.7k
Avraham Amar Israel	14	3.1k 1.0×	1.4k 1.0×	946 1.0×	612 0.9×	616 1.0×	24	3.6k
Aliza Ackerstein Israel	24	4.1k 1.3×	2.0k 1.5×	1.4k 1.5×	779 1.2×	794 1.3×	83	5.0k
HJ Kolb Germany	22	2.9k 0.9×	1.5k 1.1×	810 0.8×	620 0.9×	653 1.0×	50	3.7k
MM Horowitz United States	20	4.0k 1.3×	2.1k 1.5×	1.2k 1.2×	700 1.1×	874 1.4×	32	4.7k
R Storb United States	25	2.6k 0.8×	791 0.6×	833 0.8×	602 0.9×	546 0.9×	47	3.3k
Giuseppe Bandini Italy	29	2.4k 0.8×	1.1k 0.8×	797 0.8×	795 1.2×	422 0.7×	134	3.4k
Francis Ayuk Germany	37	2.9k 0.9×	1000 0.8×	1.2k 1.2×	818 1.2×	439 0.7×	164	3.9k
Tatjana Zabelina Germany	38	3.0k 0.9×	743 0.6×	714 0.7×	1.1k 1.6×	461 0.7×	107	3.5k
Emmanuel Clave France	28	1.9k 0.6×	1.9k 1.4×	1.0k 1.0×	317 0.5×	235 0.4×	59	3.4k

Countries citing papers authored by Simcha Samuel

Since Specialization

Citations

This map shows the geographic impact of Simcha Samuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simcha Samuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simcha Samuel more than expected).

Fields of papers citing papers by Simcha Samuel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simcha Samuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simcha Samuel. The network helps show where Simcha Samuel may publish in the future.

Co-authorship network of co-authors of Simcha Samuel

This figure shows the co-authorship network connecting the top 25 collaborators of Simcha Samuel. A scholar is included among the top collaborators of Simcha Samuel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simcha Samuel. Simcha Samuel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mevorach, Dror, Tsila Zuckerman, Avichai Shimoni, et al.. (2013). Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial. Biology of Blood and Marrow Transplantation. 20(1). 58–65. 47 indexed citations

2.

Resnick, Igor, Memet Aker, Simcha Samuel, et al.. (2009). A Retrospective Review of the Outcome after Second or Subsequent Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 15(4). 483–489. 25 indexed citations

3.

Shapira, Michael Y., Igor Resnick, Memet Aker, et al.. (2009). A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus. Cytotherapy. 11(1). 61–67. 14 indexed citations

4.

Resnick, Igor, Panagiotis Tsirigotis, Michael Y. Shapira, et al.. (2008). ABO Incompatibility is Associated with Increased Non-Relapse and GVHD Related Mortality in Patients with Malignancies Treated with a Reduced Intensity Regimen: A Single Center Experience of 221 Patients. Biology of Blood and Marrow Transplantation. 14(4). 409–417. 23 indexed citations

5.

Gesundheit, Benjamin, et al.. (2007). Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion. Leukemia Research. 32(3). 501–503. 1 indexed citations

6.

Resnick, Igor, Memet Aker, Michael Y. Shapira, et al.. (2006). Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimen. British Journal of Haematology. 133(6). 649–654. 42 indexed citations

7.

Bitan, Menachem, Michael Y. Shapira, Igor Resnick, et al.. (2005). Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells. Experimental Hematology. 33(6). 713–718. 27 indexed citations

8.

Or, Reuven, Memet Aker, Igor Resnick, et al.. (2004). Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products. Springer Seminars in Immunopathology. 26(1-2). 133–142. 12 indexed citations

9.

Bitan, Menachem, Reuven Or, Michael Y. Shapira, et al.. (2004). Early‐Onset Guillain‐Barré Syndrome Associated with Reactivation of Epstein‐Barr Virus Infection after Nonmyeloablative Stem Cell Transplantation. Clinical Infectious Diseases. 39(7). 1076–1078. 13 indexed citations

10.

Shapira, Michael Y., Pavel Kaspler, Simcha Samuel, S. Shoshan, & Reuven Or. (2003). Granulocyte colony stimulating factor does not induce long‐term DNA instability in healthy peripheral blood stem cell donors. American Journal of Hematology. 73(1). 33–36. 35 indexed citations

11.

Or, Reuven, Michael Y. Shapira, Igor Resnick, et al.. (2002). Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood. 101(2). 441–445. 151 indexed citations

12.

Slavin, S, et al.. (2001). Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases. Critical Reviews in Oncology/Hematology. 39(1-2). 25–29. 11 indexed citations

13.

Varadi, Gàbor, Reuven Or, Joseph Kapelushnik, et al.. (1999). Graft-Versus-Lymphoma Effect after Allogeneic Peripheral Blood Stem Cell Transplantation for Primary Central Nervous System Lymphoma. Leukemia & lymphoma. 34(1-2). 185–190. 36 indexed citations

14.

Slavin, Shimon, Arnon Nagler, Memet Aker, et al.. (1999). Minitransplants and cell-based therapies for malignant and nonmalignant disorders. Current Opinion in Organ Transplantation. 4(3). 184–188. 5 indexed citations

15.

Or, R., Aliza Ackerstein, Arnon Nagler, et al.. (1998). Allogeneic Cell-Mediated and Cytokine-Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation. Journal of Immunotherapy. 21(6). 447–453. 26 indexed citations

16.

Or, Reuven, Aliza Ackerstein, Arnon Nagler, et al.. (1998). Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study.. PubMed. 4(1). 1–6. 31 indexed citations

17.

Slavin, Shimon, Arnon Nagler, E Naparstek, et al.. (1998). Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases. Blood. 91(3). 756–763. 1467 indexed citations breakdown →

18.

Nagler, Arnon, Reba Condiotti, E Naparstek, et al.. (1998). SELECTIVE CD4+ T-CELL DEPLETION DOES NOT PREVENT GRAFT-VERSUS-HOST DISEASE1. Transplantation. 66(1). 138–141. 19 indexed citations

19.

Slavin, Shimon, Arnon Nagler, E Naparstek, et al.. (1998). Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases. Blood. 91(3). 756–763. 1606 indexed citations breakdown →

20.

Samuel, Simcha, Arnon Nagler, Reuven Or, & S Slavin. (1992). Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogs. Leukemia Research. 16(10). 967–972. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact